Sexually Transmitted Infections

Portfolio of sexually transmitted infection tests designed to maximise use of standard laboratory equipment and provide clinically relevant and actionable information for improved patient management.

ResistancePlus® GC

Gonorrhoea and ciprofloxacin susceptibility

Single well qPCR test for detection of Neisseria gonorrhoeae and markers linked to ciprofloxacin susceptibility validated on a range of specimens and collection vessels.

Microscopic image of Neisseria gonorrhoeae
Coloured transmission electron micrograph (TEM) of Mycoplasma genitalium

ResistancePlus® MG

Mgen and macrolide resistance

Single well qPCR test for detection of Mycoplasma genitalium (Mgen) and macrolide resistance markers validated on a range of specimens and collection vessels.

ResistancePlus® MG FleXible

Sample-to-answer Mgen and macrolide resistance

Cartridge-based test for detection of Mycoplasma genitalium (Mgen) and macrolide resistance markers for the Cepheid GeneXpert system

Mycoplasma genitalium
Microscopic image of Treponema pallidum

PlexPCR® VHS

Herpes and syphilis lesions

Single well qPCR test for detection and differentiation of herpes simplex virus (HSV-1 &  HSV-2), varicella zoster virus (VZV) and Treponema pallidum (syphilis) from genital and non-genital swabs.

PlexPCR® HSV-1&2,VZV

Herpes lesions

Single well qPCR test for detection and differentiation of herpes simplex virus (HSV-1 &  HSV-2), and varicella zoster virus (VZV) from cutaneous and mucocutaneous lesion swab specimens.

Microscopic image of Herpes Simplex Virus

  • “Testing for macrolide resistance mediating mutations in all positive samples is strongly recommended in the European Guidelines on Mycoplasma genitalium Infections. With macrolide resistance levels exceeding 50% in some settings, it will improve patient management significantly to be able to select the optimal antimicrobial treatment immediately. Avoiding unnecessary use of azithromycin is also part of antimicrobial stewardship."

    Jørgen Jensen, MD, PhD, DMSc, lead author of the IUSTI guidelines.

  • "The ResistancePlus® GC test is the first innovation in gonorrhea treatment in decades. With the continued spread of multi-drug gonorrhea, this test can make a real difference.”

    Dr. Jeffrey Klausner, Professor of Medicine and Public Health at David Geffen School of Medicine and Fielding School of Public Health, University of California, Los Angeles.